Mechanism of the vasoconstrictor action of isoprenaline on an isolated artery preparation.
D000818:Animals; D001158:Arteries / Q000187:drug effects*; D010478:Chemotherapy, Cancer, Regional Perfusion; D003042:Cocaine / Q000494:pharmacology; D004423:Ear; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects; D014043:Tolazoline / Q000494:pharmacology
D004983:Ethanolamines; D010643:Phenoxybenzamine; D006632:Histamine; D012110:Reserpine; D011433:Propranolol; D014043:Tolazoline; D003042:Cocaine; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine